Clinical trial: A randomized, Phase 3, open-label study to investigate pharmacokinetics, safety, and efficacy of subcutaneous compared to intravenous frexalimab in adult participants with multiple sclerosis.

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519304-28-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20396

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology